Fig. 3From: A new age for biomedical applications of Ribosome Inactivating Proteins (RIPs): from bioconjugate to nanoconstructsInnovative strategies to obtain a next generation of RIP based conjugates. a Metal nanoparticles consisting of RIPs and agents that drive resulting conjugate to cellular target; b Nanoconjugates obtained by combinatorial design of lipid like materials termed “lipidoids”; c Schematic representation of encapsulated RIPs in nanocapsulesBack to article page